NEW YORK (GenomeWeb News) – Complete Genomics this week provided more details on SAIC-Frederick's decision to exercise its option to have the firm sequence an additional 500 pediatric cancer cases. Complete Genomics had initially mentioned the contract during its second-quarter conference call earlier this month, but this week said that it would receive more than $8 million for completing this phase of the collaboration.
The contract follows a previous phase of the project, under which the firm sequenced 50 tumor/normal pairs from pediatric cancers.
Meridian Bioscience this week said that it will transfer the sales of its diagnostics products in Australia from its current distributor to its Bioline subsidiary that it acquired last year. Bioline makes molecular biology reagents that complement the firm's illumigene molecular diagnostics platform, and the firm believes offering the products through one source will "better serve our current customers and, at the same time, increase the opportunities to reach new ones."
Promega said this week that it has broken ground on a new cGMP facility to accommodate business growth and customers who need US Food and Drug Administration-regulated molecular biology products. The firm said the 260,000-square-foot facility will employ an additional 100 employees over the next five years.
Waters has named the Center for Proteomics at the Translational Genomics Research Institute in Phoenix as one of its Centers of Innovation. TGen is now one of fewer than 20 partners worldwide named as a Center of Innovation by the Milford, Mass.-based mass spectrometry and chromatography technology firm.
In Brief This Week is a Friday column containing news items that our readers may have missed during the week.